Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 857.25
-31.00 (-3.49%)
Aug 1, 2025, 3:29 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Active Pharmaceutical Ingredients | 7.30B | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients Growth | 1.92% | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Organization / License Fee | 2.16B | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Organization / License Fee Growth | 159.89% | Log In | Log In | Log In | Log In | Upgrade |
Formulations | 1.90B | Log In | Log In | Log In | Log In | Upgrade |
Formulations Growth | -7.61% | Log In | Log In | Log In | Log In | Upgrade |
Other | 148.23M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -0.18% | Log In | Log In | Log In | Log In | Upgrade |
Contract Research and Manufacturing Services | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Research and Manufacturing Services Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Product and Services | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Product and Services Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Power | - | Log In | Log In | Log In | Log In | Upgrade |
Power Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
India | 5.39B | Log In | Log In | Log In | Log In | Upgrade |
India Growth | 5.65% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 2.34B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 10.02% | Log In | Log In | Log In | Log In | Upgrade |
United States | 2.31B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 40.64% | Log In | Log In | Log In | Log In | Upgrade |
Rest of World | 1.47B | Log In | Log In | Log In | Log In | Upgrade |
Rest of World Growth | -9.43% | Log In | Log In | Log In | Log In | Upgrade |